期刊文献+

Alport综合征29例临床与病理分析 被引量:1

Clinicopathological Correlations of Alport Syndrome of 29 Cases
下载PDF
导出
摘要 目的:探讨Alport综合征(AS)的临床与病理关系。方法:回顾性分析1989年1月至2007年4月通过肾活检确诊的AS患儿29例的病理改变及临床特点。结果:29例患儿均有典型的AS病理特征。另外还发现伴有轻度系膜增生11例,足细胞损伤13例,节段和球性硬化2例,间质泡沫细胞5例。伴系膜增生或足细胞损伤患儿尿蛋白显著增高。结论:肾小球基底膜的改变是AS的典型特征。然而,其他非特异性的改变如系膜增生、足细胞损伤、间质泡沫细胞、节段或球性肾小球硬化也可见到,他们的出现预示着疾病向终末肾发展。 Objective:The aim of the present study was to identify the clinicopathological correlation of the Alport syndrome (AS). Methods:We reviewed clinical materials and findings of renal biopsies obtained from 25 children with AS from Jan 1989 to Dec 2005. The electron microscopy changes were emphasized at the diagnosis on AS. Results:All of AS children had typical features of glomerular basement membrane (GBM) changes. Additionally,mild mesangial hypercellurarity was observed in 11 of 25 cases,podocyte injury in 13,segmental and globe glomerulosclerosis in 2,interstitial foam cell in 5. The levels of proteinuria of AS with mild mesangial hypercelluarity and podocyte injury were higher than those of children without these changes. Conclusion:GBM changes are the typical features of AS. However,other non-specific changes that represent progressive toward ESRF such as mild mesangial hypercelluarity,podocyte injury,segmental or globe glomerulosclerosis,interstitial foam cell,and tubular changes may also be found.
出处 《长江大学学报(自科版)(下旬)》 CAS 2010年第1期J0016-J0018,共3页 Journal of Yangtze University
关键词 ALPORT综合征 肾小球基底膜 病理学 临床表现 Alport syndrome Glomerular basement membrane Pathology Clinical feature
  • 相关文献

参考文献9

  • 1Flinter F,Cameron J,Chantler C,et al.Genetics of classic Alport syndrome[J].Lancet,1988,2:1005-1007.
  • 2马捷,张泰和,周晓军,陆珍凤,孙桂勤.小儿Alport综合征的临床病理分析[J].临床与实验病理学杂志,2001,17(6):455-458. 被引量:4
  • 3郭顺华,丁洁,杨霁云.中国Alport综合征临床特点与研究现状[J].肾脏病与透析肾移植杂志,1999,8(1):71-73. 被引量:11
  • 4王芳,丁洁,俞礼霞,杨霁云.从α5(Ⅳ)链mRNA突变分析看Alport综合征基因型和表型关系[J].中华肾脏病杂志,2003,19(5):281-285. 被引量:21
  • 5Jais JP,Knebelmann B,Giatras I,et al.X-linked Alport syndrome:natural history and genotype-phenotype correlations in girls and women belonging to 195 families:A "European Community Alport Syndrome Concerted Action" study[J].J Am Soc Nephrol,2003,14:2603 -2610.
  • 6White RHR,Rafat F,Milford DV,et al.The Alport nephropathy:clinicopathological correlations[J].Pediatr Nephrol,2005,20:897-903.
  • 7Gregory MC,Terreros DA,Barker DA,et al.Alport syndrome:clinical phenotypes,incidence and pathology[J].Contrib Nephrol,1996,117:1-18.
  • 8Mazzucco G,Marchi MD,Monga G.Renal biopsy interpretation in Alport syndrome[J].Seminars in diagnostic pathology,2002,19(3):133-145.
  • 9Kashtan CE.Familial hematuria due to type IV collagen mutations:Alport syndrome and thin basement membrane nephropathy Current[J].Opinion in Pediatrics,2004,16:177-181.

二级参考文献11

共引文献30

同被引文献20

  • 1王云峰,丁洁,王芳.杂合突变型COL4A5基因表达与Alport综合征女性表型关系分析[J].中华肾脏病杂志,2005,21(1):13-17. 被引量:5
  • 2Jais JP, Knebelmann B, Giatras I, et al. X-Linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study [J]. J Am Soc Nephrol, 2003, 14(10): 2603-2610.
  • 3Crawfurd MDA, Toghill PI. Alport syndrome of hereditary nephritis and deafness [J]. Q J Med, 1968, 37(148): 563-576.
  • 4Ferguson AC, Rance CP. Hereditary nephropathy with nerve deafness (Alport syndrome) [J]. Am J Dis Child, 1972, 124(1): 84-88.
  • 5Gaboardi F, Edefonti A, Imbasciati E, et al. Alport' s syndrome (progressive hereditary nephritis) [J]. Clin Nephrol, 1974, 2(4): 143-156.
  • 6Nakanishi K, Iijima K, Kuroda N, et al. Comparison of a5 (IV) collagen chain expression in skin with disease severity in women with X-linked Alport syndrome [J]. J Am Soc Nephrol, 1998, 9(8): 1433-1440.
  • 7Flinter FA, Cameron JS, Chantler C, et al. Genetic of classic Alport's syndrome [J]. Lancet, 1998,2(8618): 1005-1007.
  • 8李运泉,王慧深.儿童高血压[J].岭南雠病杂志2011年增刊,第13届中国南方国际心血管病学术会议专刊,2011,S1:4-11.
  • 9Sigmundsson TS, Palsson R, Hardarson S, et al. Resolution of proteinuria in a patient with X-linkedAlport syndrome treated with cyclosporine [J]. ScandJUrolNephrol, 2006, 40(6): 522-525.
  • 10Massella L, Muda AO, Legato A, et al. Cyclosporine A treatment in patients with Alport syndrome: a single-center experience [J]. Pediatr Nephrol, 2010, 25(7): 1269-1275.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部